Understanding the Transition from Normal Melanocytes to Nevus to Melanoma

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

November 30, 2026

Conditions
Congenital Melanocytic NeviMelanoma, SkinNevi and Melanomas
Interventions
GENETIC

Methylomics

Methylomics analysis of FFPE blocks and frozen tissues

GENETIC

RNA sequencing

RNA sequencing of FFPE blocks and frozen tissues

GENETIC

Spatial transcriptomics

Spatial transcriptomics of FFPE blocks and frozen tissues

GENETIC

Liquid biopsy

cfDNA characterization extracted from blood/saliva

Trial Locations (2)

Unknown

RECRUITING

French National Institute of Health and Medical Research, Marseille

RECRUITING

Hospital Clínic de Barcelona (Dermatology service), Barcelona

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

UNKNOWN

collaborator

University Hospital Tuebingen

OTHER

collaborator

University of Florence

OTHER

collaborator

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER

collaborator

University Of Perugia

OTHER

collaborator

German Cancer Research Center

OTHER

collaborator

Karolinska Institutet

OTHER

collaborator

Maria Sklodowska-Curie National Research Institute of Oncology

OTHER

collaborator

Institut Curie

OTHER

collaborator

Medical University of Gdansk

OTHER

collaborator

Princess Maxima Center for Pediatric Oncology

OTHER

collaborator

Institut Català d'Oncologia

OTHER

lead

Fundacion Clinic per a la Recerca Biomédica

OTHER